Our mission is to provide
pet owners and veterinarians
with access to evidence-based
plant derived therapeutics, to
promote better health and
well-being in pets
@StockheadAU 'What’s paws for thought is the veterinary sector, given the lower regulatory hurdles and ever-expanding market as our fur-babies work their way up the evolutionary chain to true household dominance" full article here - https://t.co/B4wTyVpy54 thanks @biotech_daily
Over the course of their lifetime, pets are expensive:
🐶 $22,800
🐱 $11,800
But it's hard to put a price on the companionship, enjoyment and emotional support they provide https://t.co/UrWpxvHHLi
"The #ASX small caps looking to capitalise on post-COVID trends in animal health" | Full report by @StockheadAU featuring #CP1 Managing Director, Layton Mills https://t.co/aaB2dkCdtP
"In an Australian first, #CannPal is currently seeking registration for #DermaCann to be prescribed by vets. Currently vets are not even allowed to recommend cannabis-based products beyond nutraceuticals like #Hemp hemp seed oil." | Full report below https://t.co/ILFdK4ngPG
Cannpal has first mover advantage in the $67bn “hidden gem” animal health market🎙In this episode of The Health Kick Podcast Tim Boreham chats to Layton Mills, managing director of CannPal Animal Therapeutics $CP1 @CannPalAT
https://t.co/HTuDaMEfIk
Cannpal has first mover advantage in the $67bn “hidden gem” animal health market🎙In this episode of The Health Kick Podcast Tim Boreham chats to Layton Mills, managing director of CannPal Animal Therapeutics $CP1 @CannPalAT
https://t.co/HTuDaMEfIk